CVE-2021-38934 : Exploit Details and Defense Strategies

IBM Engineering Test Management versions 7.0, 7.0.1, and 7.0.2 are vulnerable to cross-site scripting, potentially leading to credentials disclosure within a trusted session.

Understanding CVE-2021-38934

This CVE refers to a cross-site scripting vulnerability found in IBM Engineering Test Management versions 7.0, 7.0.1, and 7.0.2.

What is CVE-2021-38934?

IBM Engineering Test Management 7.0, 7.0.1, and 7.0.2 is vulnerable to cross-site scripting. This allows users to embed JavaScript code in the Web UI, potentially leading to credentials disclosure within a trusted session.

The Impact of CVE-2021-38934

The vulnerability could be exploited by attackers to compromise user credentials and manipulate the intended functionality of the Web UI.

Technical Details of CVE-2021-38934

The following are the technical details of CVE-2021-38934:

Vulnerability Description

Cross-site scripting vulnerability in IBM Engineering Test Management versions 7.0, 7.0.1, and 7.0.2.

Affected Systems and Versions

Product: Engineering Test Management
Vendor: IBM
Vulnerable Versions: 7.0, 7.0.1, 7.0.2

Exploitation Mechanism

Attackers can exploit this vulnerability by embedding malicious JavaScript code in the Web UI, compromising sensitive data.

Mitigation and Prevention

To address CVE-2021-38934, follow these mitigation practices:

Immediate Steps to Take

Apply the official fix provided by IBM for versions 7.0, 7.0.1, and 7.0.2.
Regularly monitor for any unusual activities on the affected systems.

Long-Term Security Practices

Conduct security training to educate users on identifying and reporting suspicious activities.
Implement a robust security testing process to detect and address vulnerabilities.

Patching and Updates

Ensure that all systems running IBM Engineering Test Management are regularly updated with the latest security patches to prevent exploitation of known vulnerabilities.